제네셀, 줄기세포 상업화 첫 타깃은 '화장품'…가장 빠른 현금화 경로

Genesell's entry into the cosmetics market highlights a strategic trend where biotech firms leverage high-end skincare for early monetization to support long-term pharmaceutical R&D. The success of this move depends on establishing a premium brand identity within clinical channels to offset high raw material costs and regulatory complexities.